HPGC Renmintongtai Pharmaceutical Corporation Stock price
Equities
600829
CNE000000G05
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.57 CNY | 0.00% | -4.64% | -15.98% |
Mar. 27 | HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Dec. 18 | HPGC Renmintongtai Chairman Steps Down; Successor Named | MT |
Sales 2022 | 9.64B 1.34B | Sales 2023 | 10.39B 1.44B | Capitalization | 4.53B 628M |
---|---|---|---|---|---|
Net income 2022 | 263M 36.43M | Net income 2023 | 292M 40.45M | EV / Sales 2022 | 0.39 x |
Net Debt 2022 | 86.9M 12.04M | Net cash position 2023 | 295M 40.89M | EV / Sales 2023 | 0.41 x |
P/E ratio 2022 |
14
x | P/E ratio 2023 |
15.5
x | Employees | 3,030 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 24.93% |
1 week | -4.64% | ||
Current month | +4.62% | ||
1 month | +7.70% | ||
3 months | -14.23% | ||
6 months | -16.41% | ||
Current year | -15.98% |
Managers | Title | Age | Since |
---|---|---|---|
Wei Dong Zhu
CEO | Chief Executive Officer | 55 | - |
Ping Guan
DFI | Director of Finance/CFO | 52 | 22-04-06 |
Yu Hong Bao
ADM | Chief Administrative Officer | 50 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Xiao Dong Meng
CHM | Chairman | 52 | - |
Bo Liu
BRD | Director/Board Member | 61 | - |
Wei Dong Zhu
CEO | Chief Executive Officer | 55 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 36 M€ | +4.92% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 6.57 | 0.00% | 8,054,425 |
24-03-27 | 6.57 | -0.76% | 4,895,300 |
24-03-26 | 6.62 | -0.30% | 4,086,909 |
24-03-25 | 6.64 | -2.21% | 4,802,881 |
24-03-22 | 6.79 | -1.45% | 5,530,300 |
End-of-day quote Shanghai S.E., March 27, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-15.98% | 527M | |
+15.96% | 70.55B | |
+11.01% | 27.22B | |
-1.96% | 7.99B | |
+1.91% | 7.9B | |
-25.90% | 7.44B | |
+13.69% | 4.2B | |
+3.37% | 4.16B | |
-3.52% | 3.96B | |
+11.01% | 3.32B |